Literature DB >> 2181319

Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene.

J J Mullins1, J Peters, D Ganten.   

Abstract

PRIMARY hypertension is a polygenic condition in which blood pressure is enigmatically elevated; it remains a leading cause of cardiovascular disease and death due to cerebral haemorrhage, cardiac failure and kidney disease. The genes for several of the proteins involved in blood pressure homeostasis have been cloned and characterized, including those of the renin-angiotensin system, which plays a central part in blood pressure control. Here we describe the introduction of the mouse Ren-2 renin gene into the genome of the rat and demonstrate that expression of this gene causes severe hypertension. These transgenic animals represent a model for hypertension in which the genetic basis for the disease is known. Further, as the transgenic animals do not overexpress active renin in the kidney and have low levels of active renin in their plasma, they also provide a new model for low-renin hypertension.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181319     DOI: 10.1038/344541a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  153 in total

1.  Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Angiotensin-converting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats.

Authors:  Katsunori Isa; Amy C Arnold; Brian M Westwood; Mark C Chappell; Debra I Diz
Journal:  Hypertens Res       Date:  2011-09-22       Impact factor: 3.872

3.  A genomic analysis of rat proteases and protease inhibitors.

Authors:  Xose S Puente; Carlos López-Otín
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

4.  Central depletion of angiotensinogen is associated with elevated AT1 receptors in the SFO and PVN.

Authors:  Sherry O Kasper; Carlos M Ferrario; Detlev Ganten; Debra I Diz
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 5.  Essential hypertension--where are we going?

Authors:  H E Ives
Journal:  West J Med       Date:  1990-10

6.  New developments in renin and hypertension.

Authors:  N J Samani
Journal:  BMJ       Date:  1991-04-27

7.  Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.

Authors:  Sarka Varcabova; Zuzana Huskova; Herbert J Kramer; Sung Hee Hwang; Bruce D Hammock; John D Imig; Kento Kitada; Ludek Cervenka
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-04       Impact factor: 2.557

8.  Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases.

Authors:  Jimmy Delaney; Roselynn Chiarello; David Villar; Umadevi Kandalam; Ana Maria Castejon; Michelle A Clark
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

9.  Mechanism of cAMP regulation of renin gene transcription by proximal promoter.

Authors:  K Tamura; S Umemura; S Yamaguchi; T Iwamoto; S Kobayashi; A Fukamizu; K Murakami; M Ishii
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats.

Authors:  Karl D Pendergrass; Nancy T Pirro; Brian M Westwood; Carlos M Ferrario; K Bridget Brosnihan; Mark C Chappell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.